Jessa Boubker

GLP-1 Drugs: Brand Companies Push FDA To Limit Compounding

Cancer Drugs: Clinical Trial Issues For Antibody Drug Conjugates (ADCs)/Antibody Therapeutics

Medicare Coverage: CMS Finalizes New Pathway For Breakthrough Devices

LDTs: FDA Rolls Out A Phased Implementation For New Regulatory Requirements

2024 Health Care & Life Sciences Top Trends - Driving Tomorrow's Advances In The Health Care And Life Sciences Ecosystems

Clinical Trials: FDA Issues Finalized Charging Guidance For Investigational Drug Use

OIG Opines On Subsidizing Medicare Cost-Sharing For Clinical Trials

Decentralized Clinical Trials: Diversity In Clinical Trials

FDA Laboratory Developed Test Oversight: What Stakeholders Need To Know About Proposed Overhaul

Clinical Trials: Consent Process Clarified In New FDA Final Guidance